Management of transgenderism

JAMA

Volumn 309, Issue 5, 2013, Pages 478-484

  Spack, Norman P ^a,b,c  

^a BOSTON CHILDREN S HOSPITAL   (United States)

^b Hospital's Gender Management Service   (United States)

^c HARVARD MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTRADIOL; ESTRADIOL VALERATE; ESTROGEN; FINASTERIDE; GONADORELIN AGONIST; HISTRELIN; LEUPRORELIN; PROGESTERONE; SPIRONOLACTONE; TESTOSTERONE; TESTOSTERONE CIPIONATE; TESTOSTERONE ENANTATE;

ADOLESCENCE; ADULTHOOD; BREAST AUGMENTATION; BREAST CANCER; COUNSELING; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DRUG COST; DRUG MEGADOSE; DRUG MONITORING; DRUG RECEPTOR BINDING; FACE SURGERY; FEMALE TO MALE TRANSSEXUAL; FEMINIZATION; GENDER DYSPHORIA; HORMONAL THERAPY; HUMAN; MALE TO FEMALE TRANSSEXUAL; PATIENT MONITORING; PENIS RECONSTRUCTION; PRIORITY JOURNAL; PROLACTINOMA; PROSTATE CANCER; PSYCHOTHERAPY; REVIEW; SEX TRANSFORMATION; SEXUAL ORIENTATION; THROMBOEMBOLISM; TRANSVESTISM; UROLOGIC SURGERY; VAGINA RECONSTRUCTION;

EID: 84873273947     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2012.165234     Document Type: Review

References (37)

1. van Kesteren PJ, Gooren LJ, Megens JA. An epidemiological and demographic study of transsexuals in the Netherlands. Arch Sex Behav. 1996;25(6):589-600.
2. Cohen-Kettenis PT, Pfäfflin F. The DSM diagnostic criteria for gender identity disorder in adolescents and adults. Arch Sex Behav. 2010;39(2):499-513.
3. Cohen-Kettenis PT, Delemarre-van de Waal HA, Gooren LJ. The treatment of adolescent transsexuals: changing insights. J Sex Med. 2008;5(8):1892-1897.
4. Wallien MS, Cohen-Kettenis PT. Psychosexual outcome of gender-dysphoric children. J Am Acad Child Adolesc Psychiatry. 2008;47(12):1413-1423.
5. Zucker K, Lawrence A. Epidemiology of gender identity disorder: recommendations for the standards of care of the World Professional Association for Transgender Health. Int J Transgenderism. 2009;11:8-18.
6. Zucker KJ. Gender identity disorder in children and adolescents. Annu Rev Clin Psychol. 2005;1:467-492.
7. Smith YL, Van Goozen SH, Kuiper AJ, Cohen-Kettenis PT. Sex reassignment: outcomes and predictors of treatment for adolescent and adult transsexuals. Psychol Med. 2005;35(1):89-99.
8. Berenbaum SA, Bailey JM. Effects on gender identity of prenatal androgens and genital appearance: evidence from girls with congenital adrenal hyperplasia. J Clin Endocrinol Metab. 2003;88(3):1102-1106.
9. World Professional Association for Transgender Health. Standards of Care for the Health of Transsexual, Transgender, and Gender Nonconforming People. 7th ed. Minneapolis, MN: World Professional Association for Transgender Health; July 2011. http://www.wpath.org/documents/SOC%20V7%2003-17-12.pdf. Accessed January 10, 2013.
10. Meyer-Bahlburg HF. Intersexuality and the diagnosis of gender identity disorder. Arch Sex Behav. 1994;23(1):21-40.
11. Zhou JN, Hofman MA, Gooren LJ, Swaab DF. A sex difference in the human brain and its relation to transsexuality. Nature. 1995;378(6552):68-70.
12. Rametti G, Carrillo B, Gómez-Gil E, et al. White matter microstructure in female to male transsexuals before cross-sex hormonal treatment: a diffusion tensor imaging study. J Psychiatr Res. 2011;45(2):199-204.
13. Heylens G, De Cuypere G, Zucker KJ, et al. Gender identity disorder in twins: a review of the case report literature. J Sex Med. 2012;9(3):751-757.
14. Hembree WC, Cohen-Kettenis PT, Delemarre-van de Waal HA, et al; Endocrine Society. Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline. J Clin Endocrinol Metab. 2009;94(9):3132-3154.
15. Yager JD, Zurlo J, Ni N. Sex hormones and tumor promotion in liver. Proc Soc Exp Biol Med. 1991;198(2):667-674.
16. Toorians AW, Thomassen MC, Zweegman S, et al. Venous thrombosis and changes of hemostatic variables during cross-sex hormone treatment in transsexual people. J Clin Endocrinol Metab. 2003;88(12):5723-5729.
17. Asscheman H, Giltay EJ, Megens JA, de Ronde WP, van Trotsenburg MA, Gooren LJ. A long-term follow-up study of mortality in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2011;164(4):635-642.
18. Anderson GL, Limacher M, Assaf AR, et al; Women's Health Initiative Steering Committee. Effects of conjugated equine estrogen in postmenopausal women with hysterectomy: the Women's Health Initiative randomized controlled trial. JAMA. 2004;291(14):1701-1712.
19. Mueller A, Gooren LJ. Hormone-related tumors in transsexuals receiving treatment with cross-sex hormones. Eur J Endocrinol. 2008;159(3):197-202.
20. Gooren LJ, Giltay EJ, Bunck MC. Long-term treatment of transsexuals with cross-sex hormones: extensive personal experience. J Clin Endocrinol Metab. 2008;93(1):19-25.
21. Delemarre van de Waal HA, Cohen-Kettenis PT. Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects. Eur J Endocrinol. 2006;155(suppl):S131-S137.
22. Meyer W, Bockting WO, Cohen Kettenis PT, et al. The Harry Benjamin International Gender Dysphoria Associations' Standards of Care for Gender Identity Disorders, Sixth Version. February 2001. http://www.wpath.org/ Documents2/socv6.pdf. Accessed January 10, 2013.
23. Kreukels BP, Cohen-Kettenis PT. Puberty suppression in gender identity disorder: the Amsterdam experience. Nat Rev Endocrinol. 2011;7(8):466-472.
24. Cohen-Kettenis PT, van Goozen SH. Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent. Eur Child Adolesc Psychiatry. 1998;7(4):246-248.
25. de Vries AL, Steensma TD, Doreleijers TA, Cohen-Kettenis PT. Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study. J Sex Med. 2011;8(8):2276-2283.
26. Zucker KJ, Bradley SJ, Owen-Anderson A, Singh D, Blanchard R, Bain J. Puberty-blocking hormonal therapy for adolescents with gender identity disorder: a descriptive clinical study. J Gay Lesbian Ment Health. 2011;15:58-82.
27. Perovic S, Djinovic R. Genitoplasty in male-to-female transsexuals. Curr Opin Urol. 2009;19(6):571-576.
28. Rehman J, Lazer S, Benet AE, Schaefer LC, Melman A. The reported sex and surgery satisfactions of 28 postoperative male-to-female transsexual patients. Arch Sex Behav. 1999;28(1):71-89.
29. Lawrence AA. Patient-reported complications and functional outcomes of male-to- female sex reassignment surgery. Arch Sex Behav. 2006;35(6):717-727.
30. Klein C, Gorzalka BB. Sexual functioning in transsexuals following hormone therapy and genital surgery: a review. J Sex Med. 2009;6(11):2922-2939.
31. Hage JJ, Bloem JJ. Chest wall contouring for female-to-male transsexuals: Amsterdam experience. Ann Plast Surg. 1995;34(1):59-66.
32. Nelson L, Whallett EJ, McGregor JC. Transgender patient satisfaction following reduction mammaplasty. J Plast Reconstr Aesthet Surg. 2009;62(3):331-334.
33. Manasco PK, Pescovitz OH, Feuillan PP, et al. Resumption of puberty after long term luteinizing hormone-releasing hormone agonist treatment of central precocious puberty. J Clin Endocrinol Metab. 1988;67(2):368-372.
34. De Sutter P. Gender reassignment and assisted reproduction: present and future reproductive options for transsexual people. Hum Reprod. 2001;16(4):612-614.
35. Trans Youth Family Allies. http://imatyfa.org. Accessed January 10, 2013.
36. Gooren LJ. Care of transsexual persons. N Engl J Med. 2011;364(13):1251-1257.
37. Ainsworth TA, Spiegel JH. Quality of life of individuals with and without facial feminization surgery or gender reassignment surgery. Qual Life Res. 2010;19(7):1019-1024.